Preskoči na sadržaj
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Napredno
  • Spliceosome mutations are comm...
  • Citiraj ovo
  • Pošalji tekstualnu poruku
  • Pošalji ovo e-mailom
  • Ispiši
  • Izvezi zapis
    • Izvezi u RefWorks
    • Izvezi u EndNoteWeb
    • Izvezi u EndNote
  • Stalna poveznica
Spliceosome mutations are common in MPN-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Spliceosome mutations are common in MPN-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Bibliografski detalji
Glavni autori: Chowdhury, O, O'Sullivan, J, Barkas, N, Buck, G, Hamblin, A, Tefferi, A, Al-Ali, H, Barosi, G, Devos, T, Gisslinger, H, Jiang, Q, Kiladjian, J, Mesa, R, Passamonti, F, Ribrag, V, Schiller, G, Vannucchi, A, Zhou, D, McMullin, M, Reiser, D, Zhong, J, Gale, R, Mead, A
Format: Conference item
Izdano: American Society of Hematology 2018
  • Primjerci
  • Opis
  • Slični predmeti
  • Prikaz za djelatnike knjižnice

Slični predmeti

  • Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
    od: Chowdhury, O, i dr.
    Izdano: (2020)
  • Profile of pomalidomide and its potential in the treatment of myelofibrosis
    od: Gowin KL, i dr.
    Izdano: (2015-04-01)
  • The UK Myeloproliferative Neoplasm Registry for Myelofibrosis (UK-MPN-MF registry)
    od: Butt, N, i dr.
    Izdano: (2019)
  • Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach
    od: Alessandra Carobbio, i dr.
    Izdano: (2023-07-01)
  • P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS
    od: J.-J. Kiladjian, i dr.
    Izdano: (2022-06-01)

Opcije pretrage

  • Povijest pretrage
  • Napredna pretraga

Pronađi više

  • Pregledaj katalog
  • Pregledaj abecednim redom
  • Istraži kanale
  • Rezervacije tečajeva
  • Novi predmeti

Trebaš pomoć?

  • Savjeti za pretragu
  • Upitaj knjižničara
  • Često postavljena pitanja